Nearly 350 thousand units of pancreatic and biliary stents were sold in 2018, reflecting a valuation of around US$ 280 million for the global market, finds a recent study published by Persistence Market Research (PMR). The study primarily attributes the rise in incidence of pancreatic cancer for the increasing sales of pancreatic and biliary stents, as their adoption in the treatment for pancreatic cancer accounts for more than one-fourth revenue share of the global market.

The American Cancer Society’s estimates on the prevalence of pancreatic cancer in the United States (U.S.) state that the number of patients newly diagnosed will increase up to 57 thousand and nearly 45 thousand patients are estimated to succumb to the disease in 2019. According to the Global Cancer Observatory (GLOBOCAN), around 459 thousand new cases of pancreatic cancer were reported worldwide in 2018, and the number is likely to increase by over 355 thousand by 2040.

Being the seventh leading cause of cancer-related deaths, pancreatic cancer is growing higher in its prevalence, which is bolstering the adoption of innovative medical devices, such as pancreatic and biliary stents, to improve the effectiveness of its treatment. The PMR study projects that the demand will be mainly triggered by the rise in prevalence and incidence of pancreatic cancer in the coming years, which in turn will remain an instrumental factor in the growth of the market.

Metal Pancreatic and Biliary Stents Preferred over their Plastic Variants

In 2018, more than metal pancreatic and biliary stents accounted for nearly 95% revenue share of the global market, and this trend will continue to increase despite a slight rise in inclination towards the use of plastics, opines the PMR study. The study also opines that the demand for fully-covered pancreatic and biliary stents manufactured using metals will remain higher than non-covered or partially-covered stents in the coming years.

The primary factor that is triggering the adoption of metal over plastics in the manufacturing of pancreatic and biliary stents is that metal stents are much wider and expandable than plastic stents with a lower possibility of getting blocked easily. Furthermore, when used in the treatment for pancreatic cancer, metal pancreatic and biliary stents exhibit a greater longevity than plastic stents and a much lower chance of infection. This will continue to boost the adoption of metal over plastic among manufacturers in the pancreatic and biliary stents market.

Request For Report Sample:

Though plastic stents are highly likely to get blocked after a few months of surgery, plastic is still emerging as a fast-growing material in the market. Plastic witnessing a significant rise in adoption in pancreatic and biliary stents that are used in short term procedures such as during tests before surgery, and need to be replaced periodically. However, the use of self-expanding metal stents in pancreatic cancer treatments is considered more efficient and much cost-effective than their plastic variants, and this will continue to dictate manufacturers’ strategies in the pancreatic and biliary stents market.

Leave a comment

Your email address will not be published. Required fields are marked *